Tingal, Jovie R.

HRN: 23-74-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 1.5GM (VIAL)
10/23/2023
10/23/2023
IV
1.5gm
LD
For Primary LTCS
Waiting Final Action 
10/25/2023
CEFUROXIME 1.5GM (VIAL)
10/25/2023
10/26/2023
IV
1.5gm 3 Doses
Q8
Post CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: